Literature DB >> 6094287

Solubilized human thyrotrophin receptors behave as one class of high-affinity binding sites.

T W de Bruin, D van der Heide.   

Abstract

Evidence is presented justifying the conclusion that, in contrast to the dextran-coated charcoal technique, the widely used technique of separating bound and free TSH with polyethylene glycol is inadequate and yields inaccurate results. Optimum values for the concentration of Triton X-100, pH, salts, temperature and time of incubation were established for the TSH-TSH receptor interaction. According to Scatchard analysis, soluble TSH receptors behaved as one class of binding sites. The affinity constant for this class of binding sites (Ka 1.3 X 10(9) M-1) is identical to that for the high-affinity binding sites found in human thyroid membranes (Ka 1.2 X 10(9) M-1). No low-affinity binding sites could be detected after solubilization of membrane receptors. Chromatography experiments on Sepharose CL-6B indicated that, in excess TSH, each micelle containing TSH receptors (molecular weight 150 000) binds 4 [125I]TSH molecules. These data, together with the absence of low-affinity binding sites, led to the hypothesis that high-affinity TSH binding sites may be formed by the clustering of 4 low-affinity binding sites. Cross-reactivity experiments showed that both alpha- and beta-subunits are involved in the binding of TSH to its receptor; the TSH beta-subunit showed an increased cross-reactivity with soluble receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094287     DOI: 10.1016/0303-7207(84)90104-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy.

Authors:  T W De Bruin; N A Patwardhan; R S Brown; L E Braverman
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

2.  Difference in species specificity of TSH receptor antibodies in Graves' disease and Hashimoto's thyroiditis.

Authors:  T W de Bruin
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.